ARCA biopharma welcomes Jacob Ma-Weaver to its Board of Directors

– USA, CO –  ARCA biopharma, Inc. (Nasdaq: ABIO) today announced the appointment of Jacob Ma-Weaver to its Board of Directors.

“We are pleased to welcome Jacob Ma-Weaver, the managing member of ARCA’s largest shareholder, to our Board. We appreciate his participation and input as we explore and evaluate strategic options for maximizing stockholder value,” said Board chairman, Bob Conway.

About Jacob Ma-Weaver

Jacob Ma-Weaver is the Managing Member of Cable Car Capital LLC, an investment adviser he founded in 2013. Cable Car Capital LLC is the General Partner of The Funicular Fund, LP, a hedge fund. Since 2013, Mr. Ma-Weaver has been continuously involved in implementing the firm’s investment approach through the fund and its predecessor accounts. From 2012 to 2013, Mr. Ma-Weaver was employed as an investment analyst at Amici Capital LLC, where he focused on healthcare. He was previously employed as an equity research associate at Dodge & Cox and a corporate finance business analyst at McKinsey & Company.

Mr. Ma-Weaver received a Bachelor of Arts in Comparative Literature & Society and Economics and a Master of Arts in Statistics from Columbia University. He is a Chartered Financial Analyst charter holder.

About ARCA biopharma

ARCA biopharma is dedicated to developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. At present, ARCA is evaluating options for the development of its assets, including partnering and other strategic options.

For more information: https://arcabio.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team